AdaptHealth (AHCO) Form 3 Initial statement of insider ownership

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

BlueMountain Capital Management, LLC

(Last) (First) (Middle)

280 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/08/2019

3. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock(1)(2)(3)	3,647,353	I	Footnotes(1)(2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The filing of this Form 3 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any share of Class A Common Stock, par value $0.0001 per share "Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

2. BMCM is the investment manager of each of: (i) BMSB L.P. ("BMSB"), which is the direct beneficial owner of 2,115,972 shares of Class A Common Stock; (ii) BlueMountain Fursan Fund L.P. ("FRSN"), which is the direct beneficial owner of 842,768 shares of Class A Common Stock; (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"), which is the direct beneficial owner of 688,613 shares of Class A Common Stock; and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which is the direct beneficial owner of 150,581 shares of Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of the Issuer. BMCM, although it directs the voting and disposition of the Class A Common Stock and Class B Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock and Class B Common Stock held by the Funds.

3. Pursuant to the terms of the Exchange Agreement dated as of November 8, 2019 by and among the Issuer, AdaptHealth Holdings LLC, a subsidiary of the Issuer, and the other parties thereto, each share of Class B Common Stock, when combined with a common unit representing limited liability company interests in AdaptHealth Holdings LLC, is exchangeable at any time for one share of Class A Common Stock or, at the Issuer's election, the cash equivalent to the market value of one share of Class A Common Stock. The Class B Common Stock has no expiration date.

Remarks:

Dale Wolf serves as a director of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 3.

	BlueMountain Capital Management, LLC, By: /s/ Eric M. Albert, Chief Compliance Officer	11/18/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.